| Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute |
NCT04564716: Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus |
|
|
| Active, not recruiting | 3 | 100 | RoW | Gam-COVID-Vac, Placebo | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, RDIF (Russian Direct Investment Fund), CRO: iPharma | Covid19 | 03/21 | 04/21 | | |
RESIST, NCT04530396: Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 |
|
|
| Active, not recruiting | 3 | 33758 | RoW | Gam-COVID-Vac, placebo | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, Government of the city of Moscow, CRO: Crocus Medical BV | Covid19 Prevention | 05/21 | 05/21 | | |
SPUTNIK-UAE, NCT04656613: A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE |
|
|
| Not yet recruiting | 3 | 1000 | NA | Gam-COVID-Vac, Sputnik V, placebo | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, PDC-CRO | Covid19, SARS-CoV Infection | 08/21 | 12/21 | | |
VENEZUELA, NCT04642339: Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela |
|
|
| Not yet recruiting | 3 | 2000 | NA | Gam-COVID-Vac, Sputnik V, Placebo | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, Ministerio del Poder Popular para la Salud de la República Bolivariana de Venezuela | Covid19 | 10/21 | 12/21 | | |
NCT06068556: Study of the Vector Vaccine GamCovidVac-M (Altered Antigenic Composition) |
|
|
| Not yet recruiting | 3 | 50 | NA | GamCovidVac-M vector vaccine for the prevention of COVID-19 with altered antigenic composition | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | COVID-19 | 12/24 | 12/24 | | |
NCT06068569: Study of the Vector Vaccine GamCovidVac for the Prevention of COVID-19 With Altered Antigenic Profile With Participation of Adult Volunteers |
|
|
| Not yet recruiting | 3 | 50 | NA | GamCovidVac vector vaccine for the prevention of COVID-19 (with altered antigenic profile) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | COVID-19 | 12/24 | 12/24 | | |
NCT04640233: Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection |
|
|
| Active, not recruiting | 2/3 | 1600 | RoW | Gam-COVID-Vac, Placebo | Dr. Reddy's Laboratories Limited, Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, Russian Direct Investment Fund, CRO: JSS Medical Research India Pvt. Ltd. | COVID-19 Prevention | 08/21 | 09/21 | | |
| Recruiting | 2/3 | 3000 | RoW | Gam-COVID-vac M, Placebo | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, Moscow Healthcare Department | Covid19, Vaccine Preventable Disease | 11/22 | 12/23 | | |
| Active, not recruiting | 2b | 450 | RoW | Ad5-nCov | Fundación Huésped, Dalhousie University, CanSino Biologics Inc. | COVID-19 Vaccine | 11/22 | 04/23 | | |
NCT04587219: The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older |
|
|
| Active, not recruiting | 2 | 110 | RoW | Gam-COVID-Vac | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Coronavirus Infection | 03/21 | 04/21 | | |
NCT05027672: Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines. |
|
|
| Active, not recruiting | 2 | 348 | RoW | Gam-COVID-Vac (rAd26) / Gam-COVID-Vac (rAd5), Gam-COVID-Vac (rAd26) / ChAdOx1 nCoV-19, Gam-COVID-Vac (rAd26) / Gam-COVID-Vac (rAd26), Gam-COVID-Vac (rAd26) / mARN-1273 | Ministerio de Salud de Ciudad Autónoma de Buenos Aires | COVID-19 Vaccines | 08/21 | 09/21 | | |
NCT04983537: Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population |
|
|
| Recruiting | 2 | 120 | RoW | Gam-COVID-Vac / Gam-COVID-Vac, Gam-COVID-Vac / ChAdOx1 nCoV-19, Gam-COVID-Vac / BBIBP-CorV | Ministerio de Salud de Ciudad Autónoma de Buenos Aires | COVID-19 Vaccines | 09/21 | 09/21 | | |
| Recruiting | 2 | 1760 | RoW | COVID-19 vaccines, SPUTNIK-V (Gam-COVID-Vac), SINOPHARM (BBIBP-CorV), AstraZeneca (ChAdOx1 nCoV-19 vaccine AZD1222), Moderna (mRNA-1273 or Spikevax) | Ministry of Public Health, Argentina, Russian Direct Investment Fund | COVID-19 VACCINE, Covid19 | 09/21 | 02/22 | | |
| Active, not recruiting | 2 | 200 | RoW | BBIBP-CorV, Sinopharm | ANRS, Emerging Infectious Diseases, CEPI, Alliance for International Medical Action, Centre National de Formation et de Recherche en Sante Rurale, Institut National de la Santé Et de la Recherche Médicale, France, APHP, Agence Nationale de Sécurité Sanitaire de la Guinée (ANSS Guinée), Innovative clinical research network in vaccinology (IREIVAC) | COVID-19, Vaccine Adverse Reaction, Sars-CoV-2 Infection, Healthy Volunteer | 08/23 | 02/25 | | |
SPRAY, NCT05248373: Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray |
|
|
| Not yet recruiting | 1/2 | 400 | NA | Gam-COVID-Vac, Placebo | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | COVID-19, SARS-CoV-2 Acute Respiratory Disease | 02/23 | 12/23 | | |
NCT04871841: Study of Sputnik V COVID-19 Vaccination in Adults in Kazakhstan |
|
|
| Completed | N/A | 82 | RoW | Sputnik V, rAd26-S, rAd5-S, Gam-COVID-Vac | Karaganda Medical University, McMaster University | Covid19, Vaccine Adverse Reaction | 09/21 | 06/23 | | |
NCT04832932: The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes |
|
|
| Active, not recruiting | N/A | 2000 | Europe, US, RoW | COVID-19 vaccines, BNT162b2, mRNA-1273, JNJ-78436735, AZD1222, Gam-KOVID-Vak, CoronaVac/Sinovac, BBIBP-CorV, BBV152, NVX-CoV2373 | Mebo Research, Inc., Aurametrix | COVID-19 Vaccines | 01/23 | 01/25 | | |
| Recruiting | N/A | 30000 | Europe, Canada, US, RoW | BNT162b2, mRNA-1273, AZD1222, CoronaVac, Sinopharm, Gam-COVID-Vac, JNJ-78436735, CVnCoV, NVX-CoV2373, BBV152 | Masaryk University | Adverse Reaction to Vaccine, COVID19 Vaccine | 12/25 | 12/26 | | |